UBS Group’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.6K | Sell |
10,258
-101,262
| -91% | -$756K | ﹤0.01% | 6175 |
|
|
2025
Q1 | $1.09M | Buy |
111,520
+108,851
| +4,078% | +$1.06M | ﹤0.01% | 4133 |
|
|
2024
Q4 | $14.4K | Buy |
2,669
+2,658
| +24,164% | +$14.4K | ﹤0.01% | 6860 |
|
|
2024
Q3 | $69 | Sell |
11
-2
| -15% | -$13 | ﹤0.01% | 7983 |
|
|
2024
Q2 | $82 | Sell |
13
-7,607
| -100% | -$48K | ﹤0.01% | 8022 |
|
|
2024
Q1 | $62.5K | Sell |
7,620
-440
| -5% | -$3.61K | ﹤0.01% | 5258 |
|
|
2023
Q4 | $67.2K | Buy |
8,060
+4,284
| +113% | +$35.7K | ﹤0.01% | 5192 |
|
|
2023
Q3 | $48.7K | Sell |
3,776
-203
| -5% | -$2.62K | ﹤0.01% | 5173 |
|
|
2023
Q2 | $63.5K | Buy |
+3,979
| New | +$63.5K | ﹤0.01% | 5275 |
|
|
2022
Q4 | – | Sell |
-220
| Closed | -$2K | – | 9714 |
|
|
2022
Q3 | $2K | Buy |
220
+158
| +255% | +$1.44K | ﹤0.01% | 8642 |
|
|
2022
Q2 | $1K | Sell |
62
-79
| -56% | -$1.27K | ﹤0.01% | 8877 |
|
|
2022
Q1 | $1K | Buy |
+141
| New | +$1K | ﹤0.01% | 8833 |
|